HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Alfred O Mueck Selected Research

Progestins (Progestagens)

8/2011The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells.
5/2011Effect of drospirenone on proliferation of human benign and cancerous epithelial breast cells.
4/2011New insight on a possible mechanism of progestogens in terms of breast cancer risk.
12/2010Progestin effects in endometriosis treatment: new research on mechanisms.
10/2008Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
3/2008Are the progestins responsible for breast cancer risk during hormone therapy in the postmenopause? Experimental vs. clinical data.
11/2006The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells.
7/2005The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells.
3/2003Comparison of the effect of progesterone, medroxyprogesterone acetate and norethisterone on the proliferation of human breast cancer cells.
7/2002Medroxyprogesterone acetate versus norethisterone: effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell cultures.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Alfred O Mueck Research Topics

Disease

37Breast Neoplasms (Breast Cancer)
05/2015 - 09/2002
8Neoplasms (Cancer)
05/2013 - 09/2002
4Cardiovascular Diseases (Cardiovascular Disease)
11/2015 - 12/2003
4Endometrial Neoplasms (Endometrial Cancer)
12/2010 - 12/2003
3Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
11/2014 - 01/2004
3Venous Thromboembolism
11/2010 - 09/2005
3Atherosclerosis
03/2006 - 07/2002
2Endometriosis (Adenomyosis)
12/2010 - 01/2010
2Stroke (Strokes)
12/2009 - 09/2005
2Neoplasm Metastasis (Metastasis)
10/2008 - 04/2006
2Obesity
03/2005 - 01/2004
2Osteoporosis
01/2005 - 01/2003
2Hot Flashes
01/2005 - 01/2003
2Hypertension (High Blood Pressure)
11/2004 - 01/2004
2Atherosclerotic Plaque (Atheroma)
01/2004 - 07/2002
1Hemorrhage
11/2015
1Ovarian Neoplasms (Ovarian Cancer)
06/2015
1Vascular Diseases (Vascular Disease)
01/2015
1Insulin Resistance
11/2014
1Premature Birth (Birth, Premature)
11/2014
1Activated Protein C Resistance (APC Resistance)
11/2010
1Myocardial Infarction
12/2009
1Inflammation
11/2007
1Endometrial Hyperplasia
06/2007
1Diabetes Mellitus
01/2004

Drug/Important Bio-Agent (IBA)

22Estrogens (Estrogen)FDA Link
05/2015 - 01/2003
18HormonesIBA
06/2015 - 12/2003
14Estradiol (Estrace)FDA LinkGeneric
05/2015 - 07/2002
10Progesterone Receptors (Progesterone Receptor)IBA
10/2013 - 07/2005
10Progestins (Progestagens)IBA
08/2011 - 07/2002
5Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
10/2013 - 07/2002
5Norethindrone (Norethisterone)FDA LinkGeneric
05/2013 - 07/2002
4ProgesteroneFDA LinkGeneric
11/2014 - 03/2003
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2013 - 07/2005
3dienogestFDA Link
02/2013 - 01/2010
3DydrogesteroneFDA Link
12/2010 - 10/2007
2Combined Oral ContraceptivesIBA
11/2015 - 12/2010
22-hydroxyestroneIBA
05/2015 - 01/2010
2Conjugated (USP) Estrogens (Premarin)FDA Link
10/2013 - 09/2005
2Biological Markers (Surrogate Marker)IBA
10/2008 - 11/2007
2CholesterolIBA
01/2005 - 01/2003
2GelsIBA
01/2004 - 01/2004
1Levonorgestrel (Plan B)FDA LinkGeneric
11/2015
1Insulin (Novolin)FDA Link
11/2014
1tranilast (N 5')IBA
05/2013
1nomegestrol acetateIBA
11/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2008
1CytokinesIBA
10/2008
1Testosterone (Sustanon)FDA Link
03/2008
1norethindrone acetate (Norlutate)FDA LinkGeneric
06/2007
12-methoxyoestradiolIBA
05/2007
1SteroidsIBA
11/2006
1Adenosine Triphosphate (ATP)IBA
04/2006
1Norgestrel (DL-Norgestrel)FDA LinkGeneric
09/2005
1Plasminogen Activator Inhibitor 1IBA
03/2005
1ChemokinesIBA
01/2004
1Cell Adhesion MoleculesIBA
01/2004
1Matrix MetalloproteinasesIBA
01/2004
14-hydroxyestradiol-17 betaIBA
09/2002
1Mercaptoethanol (2 Mercaptoethanol)IBA
09/2002
14-hydroxyestroneIBA
09/2002
116-hydroxyestroneIBA
09/2002

Therapy/Procedure

14Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2015 - 10/2002
5Contraception (Birth Control)
02/2015 - 03/2008
2Estrogen Replacement Therapy
12/2010 - 10/2007
2Hysterectomy
01/2004 - 01/2004
1Intrauterine Devices (Intrauterine Device)
11/2015
1Heterologous Transplantation (Xenotransplantation)
05/2013
1Aftercare (After-Treatment)
12/2003